|
[1]
|
Torti, S.V. and Torti, F.M. (2013) Iron and Cancer: More Ore to Be Mined. Nature Reviews Cancer, 13, 342-355. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Gammella, E., Buratti, P., Cairo, G., et al. (2017) The Transferrin Receptor: The Cellular Iron Gate. Metallomics, 9, 1367-1375. [Google Scholar] [CrossRef]
|
|
[3]
|
Shen, Y., Li, X., Dong, D., et al. (2018) Transferrin Receptor 1 in Cancer: A New Sight for Cancer Therapy. American Journal of Cancer Research, 8, 916-931.
|
|
[4]
|
Xu, X., Liu, T., Wu, J., et al. (2019) Transferrin Receptor-Involved HIF-1 Signaling Path-way in Cervical Cancer. Cancer Gene Therapy, 26, 356-365. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Wang, Q., Vattai, A., Vilsmaier, T., et al. (2021) Immunoge-nomic Identification for Predicting the Prognosis of Cervical Cancer Patients. International Journal of Molecular Scienc-es, 22, Article No. 2442. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Tang, M., Zeng, L., Zeng, Z., et al. (2021) Proteomics Study of Colo-rectal Cancer and Adenomatous Polyps Identifies TFR1, SAHH, and HV307 as Potential Biomarkers for Screening. Journal of Proteomics, 243, Article ID: 104246. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Huang, N., Zhan, L., Cheng, Y., et al. (2020) TfR1 Extensively Regulates the Expression of Genes Associated with Ion Transport and Immunity. Current Medical Science, 40, 493-501. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Chen, F., Fan, Y., Hou, J., et al. (2021) Integrated Analysis Iden-tifies TfR1 as a Prognostic Biomarker Which Correlates with Immune Infiltration in Breast Cancer. Aging, 13, 21671-21699. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Candelaria, P., Leoh, L., Penichet, M., et al. (2021) An-tibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-Cancer Agents. Frontiers in Immunology, 12, Article ID: 607692. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Kleven, M., Jue, S. and Enns, C.J.B. (2018) Trans-ferrin Receptors TfR1 and TfR2 Bind Transferrin through Differing Mechanisms. Biochemistry, 57, 1552-1559. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Daniels, T., Delgado, T., Rodriguez, J., et al. (2006) The Transferrin Receptor Part I: Biology and Targeting with Cytotoxic Antibodies for the Treatment of Cancer. Clinical Im-munology, 121, 144-158. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
赵充. 转铁蛋白受体TFRC调节鼻咽癌放射敏感性的作用和机制以及化疗联合靶向治疗提高转移鼻咽癌疗效的临床试验[D]: [博士学位论文]. 武汉: 武汉大学, 2019.
|
|
[13]
|
Xue, X., Ramakrishnan, S., Weisz, K., et al. (2016) Iron Uptake via DMT1 Integrates Cell Cycle with JAK-STAT3 Signaling to Promote Colorectal Tumorigenesis. Cell Metabolism, 24, 447-461. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Gozzelino, R. and Arosio, P. (2015) The Importance of Iron in Pathophysiologic Conditions. Frontiers in Pharmacology, 6, Article No. 26. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Jomova, K. and Valko, M.J.T. (2011) Advances in Metal-Induced Oxidative Stress and Human Disease. Toxicology, 283, 65-87. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Hentze, M., Muckenthaler, M. and Andrews, N.J.C. (2004) Bal-ancing Acts: Molecular Control of Mammalian Iron Metabolism. Cell, 117, 285-297. [Google Scholar] [CrossRef]
|
|
[17]
|
Zhang, J., Hu, W., Ding, C., et al. (2019) Deferoxamine In-hibits Iron-Uptake Stimulated Osteoclast Differentiation by Suppressing Electron Transport Chain and MAPKs Signaling. Toxicology Letters, 313, 50-59. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Laube, F. and Glanz, D. (2017) Modulation of Melanotransferrin and Transferrin Receptor 1 (TFRC)- and CD44-Based Signaling for TFRC Up-Regulation in Human Melanoma Cells. Anticancer Research, 37, 3001-3007. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Testi, C., Boffi, A. and Montemiglio, L.C. (2019) Structural Anal-ysis of the Transferrin Receptor Multifaceted Ligand(s) Interface. Biophysical Chemistry, 254, Article ID: 106242. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Shi, J., Wu, P., Sheng, L., et al. (2021) Ferroptosis-Related Gene Signature Predicts the Prognosis of Papillary Thyroid Carcinoma. Cancer Cell International, 21, 669. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Lin, T., Peng, W., Mai, P., et al. (2021) Human Gastric Cancer Stem Cell (GCSC) Markers Are Prognostic Factors Correlated with Immune Infiltration of Gastric Cancer. Frontiers in Molecular Biosciences, 8, Article ID: 626966. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Fillebeen, C., Charlebois, E., Wagner, J., et al. (2019) Transferrin Receptor 1 Controls Systemic Iron Homeostasis by Fine-Tuning Hepcidin Expression to Hepatocellular Iron Load. Blood, 133, 344-355. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Johnson, I., Parkinson-Lawrence, E., Shandala, T., et al. (2014) Altered Endosome Biogenesis in Prostate Cancer Has Biomarker Potential. Molecular Cancer Research, 12, 1851-1862. [Google Scholar] [CrossRef]
|
|
[24]
|
Shen, Y., Li, X., Zhao, B., et al. (2018) Iron Metabolism Gene Expression and Prognostic Features of Hepatocellular Carcinoma. Journal of Cellular Biochemistry, 119, 9178-9204. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Xiao, C., Fu, X., Wang, Y., et al. (2020) Transferrin Re-ceptor Regulates Malignancies and the Stemness of Hepatocellular Carcinoma-Derived Cancer Stem-Like Cells by Af-fecting Iron Accumulation. PLOS ONE, 15, e0243812. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Menghini, S., Ho, P., Gwisai, T., et al. (2021) Magnetospiril-lum magneticum as a Living Iron Chelator Induces TfR1 Upregulation and Decreases Cell Viability in Cancer Cells. In-ternational Journal of Molecular Sciences, 22, Article No. 498. [Google Scholar] [CrossRef]
|
|
[27]
|
Sun, J., Zhang, N., Xu, R., et al. (2021) Tumor Cell-Imposed Iron Restriction Drives Immunosuppressive Polarization of Tumor-Associated Macrophages. Journal of Translational Medi-cine, 19, 347. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Xiong, Q., Li, X., Li, W., et al. (2021) WDR45 Mutation Im-pairs the Autophagic Degradation of Transferrin Receptor and Promotes Ferroptosis. Frontiers in Molecular Biosciences, 8, Article ID: 645831. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
刘佩佩, 杨冬梅, 夏琼, 等. 转铁蛋白受体1与早期生长反应因子4在宫颈癌组织中的表达及其临床意义[J]. 现代免疫学, 2019, 39(4): 302-306.
|
|
[30]
|
陈媛媛, 王斌俏, 兰霄霄, 等. 转铁蛋白受体在子宫颈癌中的表达及其临床意义[J]. 温州医科大学学报, 2017, 47(4): 254-257+262.
|
|
[31]
|
Wilczyński, J., Wilczyński, M. and Paradowska, E. (2022) Cancer Stem Cells in Ovarian Can-cer—A Source of Tumor Success and a Challenging Target for Novel Therapies. International Journal of Molecular Sciences, 23, Article No. 2496. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Basuli, D., Tesfay, L., Deng, Z., et al. (2017) Iron Addiction: A Novel Therapeutic Target in Ovarian Cancer. Oncogene, 36, 4089-4099. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Huang, Y., Huang, J., Huang, Y., et al. (2020) TFRC Promotes Epitheli-al Ovarian Cancer Cell Proliferation and Metastasis via Up-Regulation of AXIN2 Expression. American Journal of Cancer Research, 10, 131-147.
|
|
[34]
|
Maruthanila, V., Elancheran, R., Kunnumakkara, A., et al. (2017) Recent Devel-opment of Targeted Approaches for the Treatment of Breast Cancer. Breast Cancer, 24, 191-219. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Pizzamiglio, S., De Bortoli, M., Taverna, E., et al. (2017) Ex-pression of Iron-Related Proteins Differentiate Non-Cancerous and Cancerous Breast Tumors. International Journal of Molecular Sciences, 18, Article No. 410. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Yu, H., Yang, C., Jian, L., et al. (2019) Sulfasalazine-Induced Ferrop-tosis in Breast Cancer Cells Is Reduced by the Inhibitory Effect of Estrogen Receptor on the Transferrin Receptor. On-cology Reports, 42, 826-838. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Yin, W.J., Liao, F.C., Chen, M.J., et al. (2021) Immune Infiltration and a Ferroptosis-Associated Gene Signature for Predicting the Prognosis of Patients with Endometrial Cancer. Aging, 13, 16713-16732. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Kabat, G., Miller, A., Jain, M., et al. (2008) Dietary Iron and Haem Iron Intake and Risk of Endometrial Cancer: A Prospective Cohort Study. British Journal of Cancer, 98, 194-198. [Google Scholar] [CrossRef] [PubMed]
|